Literature DB >> 19952075

The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Barbara Stanley1, Larry J Siever.   

Abstract

Borderline personality disorder is characterized by affective instability, impulsivity, identity diffusion, and interpersonal dysfunction. Perceived rejection and loss often serve as triggers to impulsive, suicidal, and self-injurious behavior, affective reactivity, and angry outbursts, suggesting that the attachment and affiliative system may be implicated in the disorder. Neuropeptides, including the opioids, oxytocin, and vasopressin, serve a crucial role in the regulation of affiliative behaviors and thus may be altered in borderline personality disorder. While clinical data are limited, the authors propose alternative neuropeptide models of borderline personality disorder and review relevant preclinical research supporting the role of altered neuropeptide function in this disorder in the hope of stimulating more basic research and the development of new treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952075      PMCID: PMC4176877          DOI: 10.1176/appi.ajp.2009.09050744

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  142 in total

Review 1.  Dialectical behavior therapy for treatment of borderline personality disorder: implications for the treatment of substance abuse.

Authors:  M M Linehan
Journal:  NIDA Res Monogr       Date:  1993

2.  Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women.

Authors:  J A Amico; J M Johnston; A H Vagnucci
Journal:  Endocr Res       Date:  1994-02       Impact factor: 1.720

3.  Pain perception in self-injurious borderline patients: naloxone effects.

Authors:  M J Russ; S D Roth; T Kakuma; K Harrison; J W Hull
Journal:  Biol Psychiatry       Date:  1994-02-01       Impact factor: 13.382

4.  CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers.

Authors:  M Virkkunen; R Rawlings; R Tokola; R E Poland; A Guidotti; C Nemeroff; G Bissette; K Kalogeras; S L Karonen; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1994-01

5.  Subtypes of self-injurious patients with borderline personality disorder.

Authors:  M J Russ; E N Shearin; J F Clarkin; K Harrison; J W Hull
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

6.  Molecular cloning and functional expression of a mu-opioid receptor from rat brain.

Authors:  Y Chen; A Mestek; J Liu; J A Hurley; L Yu
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

7.  A role for central vasopressin in pair bonding in monogamous prairie voles.

Authors:  J T Winslow; N Hastings; C S Carter; C R Harbaugh; T R Insel
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

8.  High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats.

Authors:  K Uvnäs-Moberg; S Ahlenius; V Hillegaart; P Alster
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

Review 9.  Control of human aggression. A comparative perspective.

Authors:  R K Lore; L A Schultz
Journal:  Am Psychol       Date:  1993-01

10.  Pain perception in self-injurious patients with borderline personality disorder.

Authors:  M J Russ; S D Roth; A Lerman; T Kakuma; K Harrison; R D Shindledecker; J Hull; S Mattis
Journal:  Biol Psychiatry       Date:  1992-09-15       Impact factor: 13.382

View more
  53 in total

Review 1.  Suicidal risk and management in borderline personality disorder.

Authors:  Marianne Goodman; Tracey Roiff; Allison H Oakes; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Diagnosing and managing violence.

Authors:  Jeffrey C Fetter
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Laurel Chiappetta; Neale Scott Mason; Carl Becker; Julie C Price
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

4.  The Roles of Emotion Regulation Difficulties and Impulsivity in the Associations between Borderline Personality Disorder Symptoms and Frequency of Nonprescription Sedative Use and Prescription Sedative/Opioid Misuse.

Authors:  Julia R Richmond; Matthew T Tull; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2020-03-16

5.  Family study of borderline personality disorder and its sectors of psychopathology.

Authors:  John G Gunderson; Mary C Zanarini; Lois W Choi-Kain; Karen S Mitchell; Kerry L Jang; James I Hudson
Journal:  Arch Gen Psychiatry       Date:  2011-07

Review 6.  Reinventing intention: 'self-harm' and the 'cry for help' in postwar Britain.

Authors:  Chris Millard
Journal:  Curr Opin Psychiatry       Date:  2012-11       Impact factor: 4.741

7.  The neurobiology of empathy in borderline personality disorder.

Authors:  Luis H Ripoll; Rebekah Snyder; Howard Steele; Larry J Siever
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

8.  Affective behavior during mother-daughter conflict and borderline personality disorder severity across adolescence.

Authors:  Diana J Whalen; Lori N Scott; Karen P Jakubowski; Dana L McMakin; Alison E Hipwell; Jennifer S Silk; Stephanie D Stepp
Journal:  Personal Disord       Date:  2014-01

9.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

10.  Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls.

Authors:  Vassilis N Panagopoulos; Timothy J Trull; Anne L Glowinski; Michael T Lynskey; Andrew C Heath; Arpana Agrawal; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery; Elliot C Nelson
Journal:  Drug Alcohol Depend       Date:  2012-12-12       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.